Seeking Alpha

Alcon Announces CE Mark Approval and Commercialization of Clareon Vivity IOL in Europe, Expanding Visual Possibilities

GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced that Vivity ®, the most widely implanted 9 extended ...
Nasdaq

Alcon: Clareon Vivity IOL Gets CE Mark Approval; To Market In Europe From Early Q2

(RTTNews) - Eye care firm Alcon Inc.(ALC) announced Tuesday that Vivity, an extended depth of focus or EDOF intraocular lens or IOL, is now available on the company's most advanced lens ...
Nasdaq

New Head-to-Head Data Show Clareon Monofocal IOLs and TECNIS Eyhance Monofocal IOLs Provide Similar Range of Vision

FORT WORTH, Texas--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced results from a new study presented at the ...
Business Wire

Vivity, the World’s Leading EDOF IOL, Reaches One Million Milestone

“Reaching the one million milestone for Vivity, the world's leading EDOF IOL, represents a meaningful achievement in restoring distance, intermediate and functional near vision for people worldwide, ...
Seeking Alpha

Alcon Underscores Benefits of Its IOLs and Cataract Surgical Equipment at APACRS

Data on Alcon’s products across cataract, refractive, diagnostics and ocular health will be featured in presentations during the meeting Prospective analyses and studies demonstrate sustained ...
Morningstar

Alcon Launches Groundbreaking Innovations and Highlights New Study Findings at ESCRS 2025

†Compared to CENTURION and CONSTELLATION Vision Systems. Based on bench data. **Based on worldwide unit sales of AcrySof® IQ Vivity and Clareon Vivity IOLs, as of Q4, 2024. “As ophthalmic practices ...